533
Views
45
CrossRef citations to date
0
Altmetric
Review Article

Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies

, &
Pages 323-357 | Received 12 Oct 2011, Accepted 06 Mar 2012, Published online: 18 Apr 2012

References

  • Ahonen M. (1991). Neurofilament immunoreactivity and acetylcholinesterase activity in the developing sympathetic tissues of the rat. Histochemistry 96:467–478.
  • Alam SN, Roberts RJ, Fischer LJ. (1977). Age-related differences in salicylamide and acetaminophen conjugation in man. J Pediatr 90:130–135.
  • Alcorn J, McNamara PJ. (2003). Pharmacokinetics in the newborn. Adv Drug Deliv Rev 55:667–686.
  • Alcorn J, Elbarbry FA, Allouh MZ, McNamara PJ. (2007). Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome P450 activity. Drug Metab Dispos 35:2225–2231.
  • Alnouti Y, Klaassen CD. (2006). Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242–255.
  • Alnouti Y, Klaassen CD. (2008). Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol Sci 101:51–64.
  • Androutsopoulos VP, Tsatsakis AM, Spandidos DA. (2009). Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9:187.
  • Anttila S, Hukkanen J, Hakkola J, Stjernvall T, Beaune P, Edwards RJ, Boobis AR, Pelkonen O, Raunio H. (1997). Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell Mol Biol 16:242–249.
  • Asaoka Y, Sakai H, Sasaki J, Goryo M, Yanai T, Masegi T, Okada K. (2010). Changes in the gene expression and enzyme activity of hepatic cytochrome P450 in juvenile Sprague-Dawley rats. J Vet Med Sci 72:471–479.
  • Atterberry TT, Burnett WT, Chambers JE. (1997). Age-related differences in parathion and chlorpyrifos toxicity in male rats: target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol Appl Pharmacol 147:411–418.
  • Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590.
  • Baetge G, Pintar JE, Gershon MD. (1990). Transiently catecholaminergic (TC) cells in the bowel of the fetal rat: precursors of noncatecholaminergic enteric neurons. Dev Biol 141:353–380.
  • Balak KJ, Keith RH, Felder MR. (1982). Genetic and developmental regulation of mouse liver alcohol dehydrogenase. J Biol Chem 257:15000–15007.
  • Balistreri WF, Zimmer L, Suchy FJ, Bove KE. (1984). Bile salt sulfotransferase: alterations during maturation and non-inducibility during substrate ingestion. J Lipid Res 25:228–235.
  • Barker EV, Hume R, Hallas A, Coughtrie WH. (1994). Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology 134:982–989.
  • Bean R, Seckl JR, Lathe R, Martin C. (2001). Ontogeny of the neurosteroid enzyme Cyp7b in the mouse. Mol Cell Endocrinol 174:137–144.
  • Beckett GJ, Howie AF, Hume R, Matharoo B, Hiley C, Jones P, Strange RC. (1990). Human glutathione S-transferases: radioimmunoassay studies on the expression of alpha-, mu- and pi-class isoenzymes in developing lung and kidney. Biochim Biophys Acta 1036:176–182.
  • Bell DR, Plant NJ, Rider CG, Na L, Brown S, Ateitalla I, Acharya SK, Davies MH, Elias E, Jenkins NA. (1993). Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs. Biochem J 294 (Pt 1):173–180.
  • Belteki G, Kempster SL, Forhead AJ, Giussani DA, Fowden AL, Curley A, Charnock-Jones DS, Smith GC. (2010). Paraoxonase-3, a putative circulating antioxidant, is systemically up-regulated in late gestation in the fetal rat, sheep, and human. J Clin Endocrinol Metab 95:3798–3805.
  • Berdel B, Morys J, Maciejewska B, Narkiewicz O. (1996). Acetylcholinesterase activity as a marker of maturation of the basolateral complex of the amygdaloid body in the rat. Int J Dev Neurosci 14:543–549.
  • Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731–742.
  • Blake MJ, Castro L, Leeder JS, Kearns GL. (2005). Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123–138.
  • Blake MJ, Gaedigk A, Pearce RE, Bomgaars LR, Christensen ML, Stowe C, James LP, Wilson JT, Kearns GL, Leeder JS. (2007). Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther 81:510–516.
  • Blum M, Demierre A, Grant DM, Heim M, Meyer UA. (1991). Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci US 88:5237–5241.
  • Boleda MD, Farrés J, Guerri C, Parés X. (1992). Alcohol dehydrogenase isoenzymes in rat development. Effect of maternal ethanol consumption. Biochem Pharmacol 43:1555–1561.
  • Bolling BW, Court MH, Blumberg JB, Chen CY. (2011). Microsomal quercetin glucuronidation in rat small intestine depends on age and segment. Drug Metab Dispos 39:1406–1414.
  • Borlakoglu JT, Clarke S, Huang SW, Dils RR, Haegele KD, Gibson GG. (1992). Lactational transfer of 3,3′,4,4′-tetrachloro- and 2,2′,4,4′,5,5′-hexachlorobiphenyl induces cytochrome P450IVA1 in neonates. Evidence for a potential synergistic mechanism. Biochem Pharmacol 43:153–157.
  • Borlakoglu JT, Scott A, Henderson CJ, Wolf CR. (1993). Expression of P450 isoenzymes during rat liver organogenesis. Int J Biochem 25:1659–1668.
  • Brzezinski MR, Boutelet-Bochan H, Person RE, Fantel AG, Juchau MR. (1999). Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain. J Pharmacol Exp Ther 289:1648–1653.
  • Büdefeld T, Jezek D, Rozman D, Majdic G. (2009). Initiation of steroidogenesis precedes expression of cholesterologenic enzymes in the fetal mouse testes. Anat Histol Embryol 38:461–466.
  • Buratti FM, De Angelis G, Ricceri L, Venerosi A, Calamandrei G, Testai E. (2011). Foetal and neonatal exposure to chlorpyrifos: biochemical and metabolic alterations in the mouse liver at different developmental stages. Toxicology 280:98–108.
  • Burchell B, Coughtrie M, Jackson M, Harding D, Fournel-Gigleux S, Leakey J, Hume R. (1989). Development of human liver UDP-glucuronosyltransferases. Dev Pharmacol Ther 13:70–77.
  • Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, Huttner K, Hauser R. (2009). Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 117:639–644.
  • Candy JM, Perry EK, Perry RH, Bloxham CA, Thompson J, Johnson M, Oakley AE, Edwardson JA. (1985). Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neurosci Lett 61:91–95.
  • Cappiello M, Giuliani L, Rane A, Pacifici GM. (1991). Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Dev Pharmacol Ther 16:83–88.
  • Card SE, Tompkins SF, Brien JF. (1989). Ontogeny of the activity of alcohol dehydrogenase and aldehyde dehydrogenases in the liver and placenta of the guinea pig. Biochem Pharmacol 38:2535–2541.
  • Chambers JE, Chambers HW. (1990). Time course of inhibition of acetylcholinesterase and aliesterases following parathion and paraoxon exposures in rats. Toxicol Appl Pharmacol 103:420–429.
  • Chanda SM, Mortensen SR, Moser VC, Padilla S. (1997). Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison. Fundam Appl Toxicol 38:148–157.
  • Chen Y, Liu YQ, Su T, Ren X, Shi L, Liu D, Gu J, Zhang QY, Ding X. (2003). Immunoblot analysis and immunohistochemical characterization of CYP2A expression in human olfactory mucosa. Biochem Pharmacol 66:1245–1251.
  • Choonara IA, McKay P, Hain R, Rane A. (1989). Morphine metabolism in children. Br J Clin Pharmacol 28:599–604.
  • Chordikian FJ, Tabakoff B, Alivisatos SG. (1975). Ontogeny of multiple forms of monoamine oxidase in mouse brain. Brain Res 93:301–308.
  • Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I. (2003). Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91–100.
  • Chung BC, Matteson KJ, Voutilainen R, Mohandas TK, Miller WL. (1986). Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc Natl Acad Sci USA 83:8962–8966.
  • Clarke DW, Smith GN, Patrick J, Richardson B, Brien JF. (1989). Activity of alcohol dehydrogenase and aldehyde dehydrogenase in maternal liver, fetal liver and placenta of the near-term pregnant ewe. Dev Pharmacol Ther 12:35–41.
  • Clement JG. (1984). Role of aliesterase in organophosphate poisoning. Fundam Appl Toxicol 4:S96–105.
  • Cohen SN, Baumgartner R, Steinberg MS, Weber WW. (1973). Changes in the physicochemical characteristics of rabbit liver N-acetyltransferase during post-natal development. Biochim Biophys Acta 304:473–481.
  • Cole TB, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, Tward A, Lusis AJ, Jack RM, Costa LG, Furlong CE. (2003). Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357–364.
  • Corley RA, Mast TJ, Carney EW, Rogers JM, Daston GP. (2003). Evaluation of physiologically based models of pregnancy and lactation for their application in children’s health risk assessments. Crit Rev Toxicol 33:137–211.
  • Cossar D, Bell J, Strange R, Jones M, Sandison A, Hume R. (1990). The alpha and pi isoenzymes of glutathione S-transferase in human fetal lung: in utero ontogeny compared with differentiation in lung organ culture. Biochim Biophys Acta 1037:221–226.
  • Costa LG, Li WF, Richter RJ, Shih DM, Lusis A, Furlong CE. (1999). The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. Chem Biol Interact 119-120:429–438.
  • Coulter CL, Myers DA, Nathanielsz PW, Bird IM. (2000). Ontogeny of angiotensin II type 1 receptor and cytochrome P450(c11) in the sheep adrenal gland. Biol Reprod 62:714–719.
  • Court MH. (2010). Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 42:209–224.
  • Coyle JT, Yamamura HI. (1976). Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res 118:429–440.
  • Cresteil T, Beaune P, Kremers P, Celier C, Guengerich FP, Leroux JP. (1985). Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes. Eur J Biochem 151:345–350.
  • Croom EL, Stevens JC, Hines RN, Wallace AD, Hodgson E. (2009). Human hepatic CYP2B6 developmental expression: the impact of age and genotype. Biochem Pharmacol 78:184–190.
  • Cui JY, Choudhuri S, Knight TR, Klaassen CD. (2010). Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol Sci 116:32–43.
  • Czekaj P, Bryzek A, Czekaj TM, Koryciak-Komarska H, Wiaderkiewicz A, Plewka D, Sieron AL. (2010). Cytochrome P450 mRNA expressions along with in vitro differentiation of hepatocyte precursor cells from fetal, young and old rats. Folia Histochem Cytobiol 48:46–57.
  • de Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH. (1990). Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387–394.
  • de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. (1999a). Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 37:485–505.
  • de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. (1999b). Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet 36:439–452.
  • de Wildt SN, Kearns GL, Murry DJ, Koren G, van den Anker JN. (2010). Ontogeny of midazolam glucuronidation in preterm infants. Eur J Clin Pharmacol 66:165–170.
  • de Zwart L, Scholten M, Monbaliu JG, Annaert PP, Van Houdt JM, Van den Wyngaert I, De Schaepdrijver LM, Bailey GP, Coogan TP, Coussement WC, Mannens GS. (2008). The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 26:220–230.
  • Denlinger CL, Vesell ES. (1989). Hormonal regulation of the developmental pattern of epoxide hydrolases. Studies in rat liver. Biochem Pharmacol 38:603–610.
  • Deren JS. (1971). Development of structure and function in the fetal and newborn stomach. Am J Clin Nutr 24:144–159.
  • Dolphin CT, Cullingford TE, Shephard EA, Smith RL, Phillips IR. (1996). Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. Eur J Biochem 235:683–689.
  • Dorman DC, Allen SL, Byczkowski JZ, Claudio L, Fisher JE Jr, Fisher JW, Harry GJ, Li AA, Makris SL, Padilla S, Sultatos LG, Mileson BE. (2001). Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect 109 Suppl 1:101–111.
  • Dourson M, Charnley G, Scheuplein R, Barkhurst M. (2004). Chemicals and drugs risk assessment differential sensitivity of children and adults to chemical toxicity. Hum Ecol Risk Assess 10, 21–27.
  • Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge-Morris M. (2006). Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 316:1310–1317.
  • Dunn RT 2nd, Gleason BA, Hartley DP, Klaassen CD. (1999). Postnatal ontogeny and hormonal regulation of sulfotransferase SULT1B1 in male and female rats. J Pharmacol Exp Ther 290:319–324.
  • Durrington PN, Mackness B, Mackness MI. (2001). Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21:473–480.
  • Ecobichon DJ, Stephens DS. (1973). Perinatal development of human blood esterases. Clin Pharmacol Ther 14:41–47.
  • Ecobichon DJ. The perinatal guinea pig as a model for toxicological studies. In: Toxicology and the Newborn. S. Kacew and M.J. Reasor, eds. New York: Elsevier Science Publisher B.V., 1984. pp. 34–65.
  • Eidne KA, Bass NM, Sherman M, Millar RP, Kirsch RE. (1984). Ligandin concentrations in the steroidogenic tissues of the rat during development. Biochim Biophys Acta 801:424–428.
  • Ejiri N, Katayama K, Doi K. (2005). Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta. Exp Mol Pathol 78:150–155.
  • Elbarbry F, Alcorn J. (2009). Ontogeny of glutathione and glutathione-related antioxidant enzymes in rat liver. Res Vet Sci 87:242–244.
  • Elbarbry FA, McNamara PJ, Alcorn J. (2007). Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat. J Biochem Mol Toxicol 21:41–50.
  • Elbarbry FA. (2006). Ontogeny of rat CYP2E1 and CYP1A2: a characterization and a pharmacokinetic model, Ph.D. thesis submitted to the College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
  • Eltom SE, Babish JG, Schwark WS. (1993). The postnatal development of drug-metabolizing enzymes in hepatic, pulmonary and renal tissues of the goat. J Vet Pharmacol Ther 16:152–163.
  • Eltom SE, Schwark WS. (1999). CYP1A1 and CYP1B1, two hydrocarbon-inducible cytochromes P450, are constitutively expressed in neonate and adult goat liver, lung and kidney. Pharmacol Toxicol 85:65–73.
  • Enayetallah AE, French RA, Thibodeau MS, Grant DF. (2004). Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52:447–454.
  • Estonius M, Svensson S, Höög JO. (1996). Alcohol dehydrogenase in human tissues: localisation of transcripts coding for five classes of the enzyme. FEBS Lett 397:338–342.
  • Estrada L, Kanelakis KC, Levy GN, Weber WW. (2000). Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1. Drug Metab Dispos 28:139–146.
  • Estrada-Rodgers L, Levy GN, Weber WW. (1998). Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells. Drug Metab Dispos 26:502–505.
  • Fakis G, Boukouvala S, Buckle V, Payton M, Denning C, Sim E. (2000). Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2. Cytogenet Cell Genet 90:134–138.
  • Falany CN, Li G. (2005). Effects of age and pregnancy on cytochrome P450 induction by octamethyltetracyclosiloxane in female Sprague-Dawley rats. J Biochem Mol Toxicol 19:129–138.
  • Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. (2011). Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics 3, 53–72.
  • Foxenberg RJ. (2007). Generation of physiologically relevant kinetic data for the refinement of a human CYP-specific physiologically based pharmacokinetic/pharmacodynamic model to improve to improve the risk assessment of two organophosphate pesticides: parathion and chlorpyrifos. Ph.D. dissertation, State University of New York, University of Buffalo, Department of Pharmacology and Toxicology. P 182.
  • FQPA. (1996). Food Quality Protection Act. Public Law No. 104–170.
  • Fryer AA, Hume R, Strange RC. (1986). The development of glutathione S-transferase and glutathione peroxidase activities in human lung. Biochim Biophys Acta 883:448–453.
  • Ganiere-Monteil C, Medard Y, Lejus C, Bruneau B, Pineau A, Fenneteau O, Bourin M, Jacqz-Aigrain E. (2004). Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol 60:89–96.
  • Gasser R, Philpot RM. (1989). Primary structures of cytochrome P-450 isozyme 5 from rabbit and rat and regulation of species-dependent expression and induction in lung and liver: identification of cytochrome P-450 gene subfamily IVB. Mol Pharmacol 35:617–625.
  • Gebremichael A, Chang AM, Buckpitt AR, Plopper CG, Pinkerton KE. (1995). Postnatal development of cytochrome P4501A1 and 2B1 in rat lung and liver: effect of aged and diluted sidestream cigarette smoke. Toxicol Appl Pharmacol 135:246–253.
  • Gibbs JP, Liacouras CA, Baldassano RN, Slattery JT. (1999). Up-regulation of glutathione S-transferase activity in enterocytes of young children. Drug Metab Dispos 27:1466–1469.
  • Gilham DE, Cairns W, Paine MJ, Modi S, Poulsom R, Roberts GC, Wolf CR. (1997). Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica 27:111–125.
  • Gilissen RA, Hume R, Meerman JH, Coughtrie MW. (1994). Sulphation of N-hydroxy-4-aminobiphenyl and N-hydroxy-4-acetylaminobiphenyl by human foetal and neonatal sulphotransferase. Biochem Pharmacol 48:837–840.
  • Ginsberg G, Hattis D, Sonawane B, Russ A, Banati P, Kozlak M, Smolenski S, Goble R. (2002). Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol Sci 66:185–200.
  • Glatt H. (2000). Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129:141–170.
  • Greger DL, Philipona C, Blum JW. (2006). Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle. Domest Anim Endocrinol 31:76–87.
  • Gu J, Su T, Chen Y, Zhang QY, Ding X. (2000). Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity. Toxicol Appl Pharmacol 165:158–162.
  • Guengerich FP. (2008). Oxidative, reductive and hydrolytic metabolism of drugs, In Drug metabolism in drug design and development (Zhang D, Zhu M, Griffith Humphreys W edts), John Wiley & Sons, Inc., Hoboken, New Jersey, pp. 15–36.
  • Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, Hall SD. (1996). Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 50:52–59.
  • Hahn T, Desoye G, Lang I, Skofitsch G. (1993). Location and activities of acetylcholinesterase and butyrylcholinesterase in the rat and human placenta. Anat Embryol 188:435–440.
  • Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, Rane A, Mäntylä M, Purkunen R, Saarikoski S, Tooming M, Raunio H. (1997). Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18:391–397.
  • Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Mäenpää J, Rane A, Raunio H. (1994). Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 48:59–64.
  • Hakkola J, Pelkonen O, Pasanen M, Raunio H. (1998). Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit Rev Toxicol 28:35–72.
  • Hansen LG, Shane BS. (1994). Xenobiotic metabolism. In: Cockerham LG, Shane BS, eds. Basic environmental toxicology. Boca Raton, Florida: CRC Press, Inc., 49–105.
  • Harada N, Yamada K. (1992). Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction. Endocrinology 131:2306–2312.
  • Harris C, Thomas DE, Carter MW, Bradshaw WS. (1991). Fetotoxic alterations in the normal ontogenies of rat microsomal and lysosomal enzymes. J Biochem Toxicol 6:181–194.
  • Harris C, Wang SW, Lauchu JJ, Hansen JM. (2003). Methanol metabolism and embryotoxicity in rat and mouse conceptuses: comparisons of alcohol dehydrogenase (ADH1), formaldehyde dehydrogenase (ADH3), and catalase. Reprod Toxicol 17:349–357.
  • Hart SN, Cui Y, Klaassen CD, Zhong XB. (2009). Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos 37:116–121.
  • Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong CE. (1991). Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 30:10141–10149.
  • Hattis D, Ginsberg G, Sonawane B, Smolenski S, Russ A, Kozlak M, Goble R. (2003). Differences in pharmacokinetics between children and adults–II. Children’s variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal 23:117–142.
  • Hayes JD, Pulford DJ. (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445–600.
  • Hein DW, Trinidad A, Yerokun T, Ferguson RJ, Kirlin WG, Weber WW. (1988). Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse. Drug Metab Dispos 16:341–347.
  • Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xio GH, Devanaboyina US, Nagju NA, Feng Y. (2002). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomark Prev 9:29–42.
  • Henderson CJ, Bammler T, Wolf CR. (1994). Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney. Biochim Biophys Acta 1200:182–190.
  • Her C, Kaur GP, Athwal RS, Weinshilboum RM. (1997). Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization. Genomics 41:467–470.
  • Hiley C, Bell J, Hume R, Strange R. (1989). Differential expression of alpha and pi isoenzymes of glutathione S-transferase in developing human kidney. Biochim Biophys Acta 990:321–324.
  • Hines RN, McCarver DG. (2002). The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300:355–360.
  • Hines RN. (2008). The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118:250–267.
  • Holmes RS. (1979a). Genetics and ontogeny of alcohol dehydrogenase isozymes in the mouse: evidence for a cis-acting regulator gene (Adt-i) controlling C2 isozyme expression in reproductive tissues and close linkage of Adh-3 and Adt-i on chromosome 3. Biochem Genet 17:461–472.
  • Holmes RS. (1979b). Genetics, ontogeny, and testosterone inducibility of aldehyde oxidase isozymes in the mouse: evidence for two genetic loci (Aox-I and Aox-2) closely linked on chromosome 1. Biochem Genet 17:517–527.
  • Hong JY, Pan JM, Dong ZG, Ning SM, Yang CS. (1987). Regulation of N-nitrosodimethylamine demethylase in rat liver and kidney. Cancer Res 47:5948–5953.
  • Horbach GJ, Van Asten JG, Rietjens IM, Kremers P, Van Bezooijen CF. (1992). The effect of age on inducibility of various types of rat liver cytochrome P-450. Xenobiotica 22:515–522.
  • Hsu MH, Savas U, Griffin KJ, Johnson EF. (2007). Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev 39:515–538.
  • Huang CT, Rodriguez JT, Woodward WE, Nichols BL. (1976). Comparison of patterns of fecal bile acid and neutral sterol between children and adults. Am J Clin Nutr 29:1196–1203.
  • Huen K, Harley K, Brooks J, Hubbard A, Bradman A, Eskenazi B, Holland N. (2009). Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms. Environ Health Perspect 117:1632–1638.
  • Hume R, Barker EV, Coughtrie MW. (1996a). Differential expression and immunohistochemical localisation of the phenol and hydroxysteroid sulphotransferase enzyme families in the developing lung. Histochem Cell Biol 105:147–152.
  • Hume R, Burchell A, Allan BB, Wolf CR, Kelly RW, Hallas A, Burchell B. (1996b). The ontogeny of key endoplasmic reticulum proteins in human embryonic and fetal red blood cells. Blood 87:762–770.
  • Hume R, Coughtrie MW, Burchell B. (1995). Differential localisation of UDP-glucuronosyltransferase in kidney during human embryonic and fetal development. Arch Toxicol 69:242–247.
  • Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, Wojnowski L. (2001). The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11:773–779.
  • Ichikawa H, Matsuo S, Wakisaka S, Akai M. (1991). Ontogeny of cholinergic ganglionic cells which take up L-3,4-dihydroxyphenylalanine and contain vasoactive intestinal polypeptide in the mouse tongue. Acta Anat (Basel) 140:135–138.
  • ICRP (2003). Publication 89: Basic anatomical and physiological data for use in radiological protection: reference values. Oxford, UK: Elsevier Science Ltd.
  • Ilhan A, Gartner W, Nabokikh A, Daneva T, Majdic O, Cohen G, Böhmig GA, Base W, Hörl WH, Wagner L. (2008). Localization and characterization of the novel protein encoded by C20orf3. Biochem J 414:485–495.
  • Imaoka S, Fujita S, Funae Y. (1991). Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta 1097:187–192.
  • Irizar A, Ioannides C. (1995). Expression and inducibility of cytochrome P450 proteins belonging to families 2,3 and 4 in the rabbit aorta. Biochem Biophys Res Commun 213:916–921.
  • James MO. (2011). Ontogeny of hepatic glutathione transferase enzymes in humans. Presented at the 17th North American Regional ISSX Meeting, Atlanta, GA.
  • Johnson EF, Walker DL, Griffin KJ, Clark JE, Okita RT, Muerhoff AS, Masters BS. (1990). Cloning and expression of three rabbit kidney cDNAs encoding lauric acid omega-hydroxylases. Biochemistry 29:873–879.
  • Johnson TN, Tanner MS, Taylor CJ, Tucker GT. (2001). Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol 51:451–460.
  • Johnson TN. (2003). The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192:37–48.
  • Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG. (2003). Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther 307:402–407.
  • Jokanovic M. (1989). Role of carboxylesterase in soman, sarin and tabun poisoning in rats. Pharmacol Toxicol 65:181–184.
  • Jones AL, Hume R, Bamforth KJ, Coughtrie MW. (1992). Estrogen and phenol sulfotransferase activities in human fetal lung. Early Hum Dev 28:65–77.
  • Josephy PD, Guengerich FP, Miners JO. (2005). “Phase I” and “Phase II” drug metabolism: terminology that we should phase out? Drug Metab Rev 37:575–580.
  • Karanth S, Pope C. (2000). Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol Sci 58:282–289.
  • Kawaji A, Isobe M, Tochino Y, Takabatake E, Chikaoka Y, Nomura Y, Tamura M. (1998). Flavin-containing monooxygenase mediated metabolism of benzydamine in perfused brain and liver. Biochim Biophys Acta 1425:41–46.
  • Kelso GJ, Stuart WD, Richter RJ, Furlong CE, Jordan-Starck TC, Harmony JA. (1994). Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry 33:832–839.
  • Kennedy B, Ziegler MG. (2000). Ontogeny of epinephrine metabolic pathways in the rat: role of glucocorticoids. Int J Dev Neurosci 18:53–59.
  • Kester MH, Kaptein E, Roest TJ, van Dijk CH, Tibboel D, Meinl W, Glatt H, Coughtrie MW, Visser TJ. (1999). Characterization of human iodothyronine sulfotransferases. J Clin Endocrinol Metab 84:1357–1364.
  • Kimoto T, Ishii H, Higo S, Hojo Y, Kawato S. (2010). Semicomprehensive analysis of the postnatal age-related changes in the mRNA expression of sex steroidogenic enzymes and sex steroid receptors in the male rat hippocampus. Endocrinology 151:5795–5806.
  • Kimura S, Donovan JC, Nebert DW. (1987). Expression of the mouse P(1)450 gene during differentiation without foreign chemical stimulation. J Exp Pathol 3:61–74.
  • Kishi M, Emi Y, Sakaguchi M, Ikushiro S, Iyanagi T. (2008). Ontogenic isoform switching of UDP-glucuronosyltransferase family 1 in rat liver. Biochem Biophys Res Commun 377:815–819.
  • Kiss J, Patel AJ. (1992). Development of the cholinergic fibres innervating the cerebral cortex of the rat. Int J Dev Neurosci 10:153–170.
  • Kopin IJ. (1985). Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37:333–364.
  • Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN. (2004). Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308:965–974.
  • Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. (2002). Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 51:236–243.
  • Krishna DR, Klotz U. (1994). Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 26:144–160.
  • Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E. (2001). Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383–391.
  • Kuntzman R, Mark LC, Brand LC, Jacobson BM, Levin W, Conney AH. (1966). Metabolism of drugs and carcinogens by human liver enzymes. J Pharmacol Exp Ther 152:151–156.
  • Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. (1997). Expression of CYP3A in the human liver–evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625–634.
  • LaKind JS, Amina Wilkins A, Berlin CM Jr. (2004). Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol 198:184–208.
  • Lang T, Klein K, Fischer J, Nüssler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM. (2001). Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 11:399–415.
  • Leakey JE, Hume R, Burchell B. (1987). Development of multiple activities of UDP-glucuronyltransferase in human liver. Biochem J 243:859–861.
  • Leeder JS, Kearns GL. (1997). Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am 44:55–77.
  • Lephart ED, Simpson ER, McPhaul MJ, Kilgore MW, Wilson JD, Ojeda SR. (1992). Brain aromatase cytochrome P-450 messenger RNA levels and enzyme activity during prenatal and perinatal development in the rat. Brain Res Mol Brain Res 16:187–192.
  • Levy E, Trudel K, Bendayan M, Seidman E, Delvin E, Elchebly M, Lavoie JC, Precourt LP, Amre D, Sinnett D. (2007). Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats. Am J Physiol Gastrointest Liver Physiol 293:G1252–G1261.
  • Li W, Gu Y, James MO, Hines RN, Simpson P, Langaee T, Stacpoole PW. (2012). Prenatal and postnatal expression of glutathione transferase ? 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetate. Drug Metab Dispos 40:232–239.
  • Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, Thummel KE. (2002). Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol 62:162–172.
  • Lindahl R. (1977). Aldehyde dehydrogenase in 2-acetamidofluorene-induced rat hepatomas. Ontogeny and evidence that the new isoenzymes are not due to normal gene de-repression. Biochem J 164:119–123.
  • Liu L, Klaassen CD. (1996a). Ontogeny and hormonal basis of female-dominant rat hepatic sulfotransferases. J Pharmacol Exp Ther 279:386–391.
  • Liu L, Klaassen CD. (1996b). Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases. Mol Pharmacol 50:565–572.
  • Lund J, Mason JI, Simpson ER, Waterman MR. (1989). Developmental regulation of P-45017 alpha gene expression in fetal bovine adrenal. Endocr Res 15:17–29.
  • Macé K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM. (1998). Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 34:914–920.
  • Mackness B, Beltran-Debon R, Aragones G, Joven J, Camps J, Mackness M. (2010). Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 62:480–482.
  • Mäenpää J, Rane A, Raunio H, Honkakoski P, Pelkonen O. (1993). Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse. Biochem Pharmacol 45:899–907.
  • Martell KJ, Levy GN, Weber WW. (1992). Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products. Mol Pharmacol 42:265–272.
  • Marty MS, Saghir SA, Clark AJ, Zablotny CL, Bus JS, Perala AW, Yano BL, Neal BH. (2009). A dietary dose range-finding and toxicokinetic (TK) study of 2,4-dichlorophenoxyacetic acid (2,4-D) in adult CRL:CD(SD) rats and their offspring: II. Toxicity. 108:1262.
  • Maslova MN, Ozirskaia EV. (1979). [External brain acetylcholinesterase in the ontogeny of precocial and altricial rodents]. Zh Evol Biokhim Fiziol 15:48–53.
  • Matsubara S, Yamamoto S, Sogawa K, Yokotani N, Fujii-Kuriyama Y, Haniu M, Shively JE, Gotoh O, Kusunose E, Kusunose M. (1987). cDNA cloning and inducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin omega-hydroxylase (cytochrome P-450p-2). J Biol Chem 262:13366–13371.
  • Matsumoto J, Yokota H, Yuasa A. (2002). Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect 110:193–196.
  • Maxwell DM. (1992). The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol Appl Pharmacol 114:306–312.
  • McCarver DG, Hines RN. (2002). The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300:361–366.
  • McCarver DG. (2004). Applicability of the principles of developmental pharmacology to the study of environmental toxicants. Pediatrics 113:969–972.
  • McCombie RR, Dolphin CT, Povey S, Phillips IR, Shephard EA. (1996). Localization of human flavin-containing monooxygenase genes FMO2 and FMO5 to chromosome 1q. Genomics 34:426–429.
  • McLeod HL, Krynetski EY, Wilimas JA, Evans WE. (1995). Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults. Pharmacogenetics 5:281–286.
  • McQueen CA, Chau B. (2003). Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity. Toxicol Sci 73:279–286.
  • McQueen CA, Mitchell MK, Dang LN, Chau B, Tjalkens RB, Philbert MA. (2003). Prenatal expression of N-acetyltransferases in C57Bl/6 mice. Chem Biol Interact 145:77–87.
  • Meyer RP, Podvinec M, Meyer UA. (2002). Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme. Mol Pharmacol 62:1061–1067.
  • Micic M, Leposavic G, Ugresic N, Bogojevic M, Isakovic K. (1992). Parasympathetic innervation of the rat thymus during first life period: histochemical and biochemical study. Thymus 19:173–182.
  • Mitra A, Hilbelink DR, Dwornik JJ, Kulkarni A. (1992). A novel model to assess developmental toxicity of dihaloalkanes in humans: bioactivation of 1,2-dibromoethane by the isozymes of human fetal liver glutathione S-transferase. Teratog, Carcinog Mutagen 12:113–127.
  • Miyagi SJ, Collier AC. (2007). Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab Dispos 35:1587–1592.
  • Mochizuki H, Scherer SW, Xi T, Nickle DC, Majer M, Huizenga JJ, Tsui LC, Prochazka M. (1998). Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 213:149–157.
  • Morselli PL. (1989). Clinical pharmacology of the perinatal period and early infancy. Clin Pharmacokinet 17 Suppl 1:13–28.
  • Moser R, Oberley TD, Daggett DA, Friedman AL, Johnson JA, Siegel FL. (1995). Effects of lead administration on developing rat kidney. I. Glutathione S-transferase isoenzymes. Toxicol Appl Pharmacol 131:85–93.
  • Muerhoff AS, Williams DE, Masters BS. (1990). Purification and properties of pregnancy-inducible rabbit lung cytochrome P-450 prostaglandin omega-hydroxylase. Meth Enzymol 187:253–267.
  • Murray GI, Foster CO, Barnes TS, Weaver RJ, Snyder CP, Ewen SW, Melvin WT, Burke MD. (1992). Cytochrome P450IA expression in adult and fetal human liver. Carcinogenesis 13:165–169.
  • Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O. (1993). The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1–51.
  • Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST. (2001). Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449.
  • Novick RM, Mitzey AM, Brownfield MS, Elfarra AA. (2009). Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes. J Pharmacol Exp Ther 329:1148–1155.
  • NRC (National Research Council). Pesticides in the diets of infants and children. Washington, DC: National Academy Press, 1993.
  • Odum J, Orton TC. (1983). Hepatic microsomal glucuronidation of clofibric acid in the adult and neonate albino rat. Biochem Pharmacol 32:3565–3569.
  • Omiecinski CJ, Aicher L, Swenson L. (1994). Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 269:417–423.
  • Omiecinski CJ, Redlich CA, Costa P. (1990). Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res 50:4315–4321.
  • Ozols J. (1999). Isolation and complete covalent structure of liver microsomal paraoxonase. Biochem J 338 (Pt 2):265–272.
  • Pacifici GM, Bencini C, Rane A. (1986). Acetyltransferase in humans: development and tissue distribution. Pharmacology 32:283–291.
  • Pacifici GM, Temellini A, Giuliani L, Rane A, Thomas H, Oesch F. (1988a). Cytosolic epoxide hydrolase in humans: development and tissue distribution. Arch Toxicol 62:254–257.
  • Pacifici GM, Franchi M, Colizzi C, Giuliani L, Rane A. (1988b). Sulfotransferase in humans: development and tissue distribution. Pharmacology 36:411–419.
  • Pacifici GM, Franchi M, Giuliani L, Rane A. (1989). Development of the glucuronyltransferase and sulphotransferase towards 2-naphthol in human fetus. Dev Pharmacol Ther 14:108–114.
  • Pacifici GM, Peng D, Rane A. (1983). Epoxide hydrolase and aryl hydrocarbon hydroxylase in human fetal tissues: activities in nuclear and microsomal fractions and in isolated hepatocytes. Pediatr Pharmacol (New York) 3:189–197.
  • Pacifici GM, Rane A. (1981). Intestinal and hepatic morphine glucuronidation in immature and pregnant rats. Dev Pharmacol Ther 3:160–167.
  • Pacifici GM, Rane A. (1983). Epoxide hydrolase in human fetal liver. Pharmacology 26:241–248.
  • Pacifici GM, Romiti P, Giuliani L, Rane A. (1991). Thiopurine methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther 17:16–23.
  • Pacifici GM, Säwe J, Kager L, Rane A. (1982). Morphine glucuronidation in human fetal and adult liver. Eur J Clin Pharmacol 22:553–558.
  • Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, Perkins JD, Thummel KE. (1997). Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 283:1552–1562.
  • Pariente-Khayat A, Pons G, Rey E, Richard MO, D’Athis P, Moran C, Badoual J, Olive G. (1991). Caffeine acetylator phenotyping during maturation in infants. Pediatr Res 29:492–495.
  • Pariente-Khayat A, Rey E, Gendrel D, Vauzelle-Kervroëdan F, Crémier O, d’Athis P, Badoual J, Olive G, Pons G. (1997). Isoniazid acetylation metabolic ratio during maturation in children. Clin Pharmacol Ther 62:377–383.
  • Park-Hah JO, Klemetsdal B, Lysaa R, Choi KH, Aarbakke J. (1996). Thiopurine methyltransferase activity in a Korean population sample of children. Clin Pharmacol Ther 60:68–74.
  • Parkinson A. (1996). Biotransformation of xenobiotics. In: Klaassen CD, ed. Casarett & Doull’s toxicology: the basic science of poisons. New York: McGraw-Hill, 113–186.
  • Partridge CA, Singh SV, Hong TD, Theodore C, Dao DD, Awasthi YC. (1985). Rat lung glutathione S-transferases: subunit structure and the interrelationship with the liver enzymes. Int J Biochem 17:331–340.
  • Pasanen M, Pelkonen O, Kauppila A, Park SS, Friedman FK, Gelboin HV. (1987). Characterization of human fetal hepatic cytochrome P-450-associated 7-ethoxyresorufin O-deethylase and aryl hydrocarbon hydroxylase activities by monoclonal antibodies. Dev Pharmacol Ther 10:125–132.
  • Pasanen M, Pelkonen O. (1986). Purification and immunological characterization of human placental mitochondrial cytochrome P-450. J Steroid Biochem 24:669–675.
  • Pasanen M, Pelkonen O. (1989). Human placental xenobiotic and steroid biotransformations catalyzed by cytochrome P450, epoxide hydrolase, and glutathione S-transferase activities and their relationships to maternal cigarette smoking. Drug Metab Rev 21:427–461.
  • Pasanen M. (1999). The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 38:81–97.
  • Patel HR, Hewer A, Hayes JD, Phillips DH, Campbell FC. (1998). Age-dependent change of metabolic capacity and genotoxic injury in rat intestine. Chem Biol Interact 113:27–37.
  • Payne AK, Morgan SE, Gandolfi AJ, Brendel K. (1995). Biotransformation of sevoflurane by rat neonate liver slices. Drug Metab Dispos 23:497–500.
  • Payton M, Smelt V, Upton A, Sim E. (1999). A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate. Biochem Pharmacol 58:779–785.
  • Pikkarainen PH, Räihä NC. (1967). Development of alcohol dehydrogenase activity in the human liver. Pediatr Res 1:165–168.
  • Plopper CG, Weir AJ, Morin D, Chang A, Philpot RM, Buckpitt AR. (1993). Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits. Mol Pharmacol 44:51–61.
  • Podosinovikova NP, Dolgo-Saburov VB. (1979). [The structural catalytic characteristics of brain acetylcholinesterase in rabbit postnatal ontogeny]. Zh Evol Biokhim Fiziol 15:54–58.
  • Polk DH. (1995). Thyroid hormone metabolism during development. Reprod Fertil Dev 7:469–477.
  • Pons G, Rey E, Carrier O, Richard MO, Moran C, Badoual J, Olive G. (1989). Maturation of AFMU excretion in infants. Fundam Clin Pharmacol 3:589–595.
  • Pope CN, Karanth S, Liu J, Yan B. (2005). Comparative carboxylesterase activities in infant and adult liver and their in vitro sensitivity to chlorpyrifos oxon. Regul Toxicol Pharmacol 42:64–69.
  • Poulsen LL, Ziegler DM. (1995). Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificity. Chem Biol Interact 96:57–73.
  • Pretheeban M, Hammond G, Bandiera S, Riggs W, Rurak D. (2011). Ontogenesis of UDP-glucuronosyltransferase enzymes in sheep. Comp Biochem Physiol, Part A Mol Integr Physiol 159:159–166.
  • Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, Enayetallah AE, Zeldin DC, Grant DF. (2003). Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64:482–490.
  • Radi ZA, Ackermann MR. (2011). Ontogeny of pulmonary cyclooxygenase-1 (COX-1) and -2 (COX-2). Pathophysiology 18:215–219.
  • Räihä NC, Koskinen M, Pikkarainen P. (1967). Developmental changes in alcohol-dehydrogenase activity in rat and guinea-pig liver. Biochem J 103:623–626.
  • Raj PP, Nelson EB, Estabrook RW. (1971). Studies on drug metabolism in human liver. Chem Biol Interact 3:303–304.
  • Ratanasavanh D, Beaune P, Morel F, Flinois JP, Guengerich FP, Guillouzo A. (1991). Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 13:1142–1151.
  • Ravindranath V, Bhamre S, Bhagwat SV, Anandatheerthavarada HK, Shankar SK, Tirumalai PS. (1995). Xenobiotic metabolism in brain. Toxicol Lett 82-83:633–638.
  • Rawat AK. (1976). Effect of maternal ethanol consumption of fetal hepatic metabolism in the rat. Ann N Y Acad Sci 273:175–187.
  • Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM. (2001). Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542–547.
  • Renaud HJ, Cui JY, Khan M, Klaassen CD. (2011). Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci 124:261–277.
  • Ribeiro V, Lechner MC. (1992). Cloning and characterization of a novel CYP3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch Biochem Biophys 293:147–152.
  • Rich KJ, Boobis AR. (1997). Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 39:424–435.
  • Rich KJ, Foster JR, Edwards RJ, Davies DS, Boobis AR. (1993). Ontogenetic development of the distribution of constitutive and 3-methylcholanthrene-induced CYP1A1 and CYP1A2 in rabbit liver. J Histochem Cytochem 41:915–925.
  • Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ, Coughtrie MW. (2001). Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab 86:2734–2742.
  • Rodrigo L, Hernández AF, López-Caballero JJ, Gil F, Pla A. (2001). Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact 137:123–137.
  • Rodrigues-Lima F, Cooper RN, Goudeau B, Atmane N, Chamagne AM, Butler-Browne G, Sim E, Vicart P, Dupret JM. (2003). Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase. J Histochem Cytochem 51:789–796.
  • Rollins DE, von Bahr C, Glaumann H, Moldéus P, Rane A. (1979). Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science 205:1414–1416.
  • Roman LJ, Palmer CN, Clark JE, Muerhoff AS, Griffin KJ, Johnson EF, Masters BS. (1993). Expression of rabbit cytochromes P4504A which catalyze the omega-hydroxylation of arachidonic acid, fatty acids, and prostaglandins. Arch Biochem Biophys 307:57–65.
  • Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F. (2003). Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387.
  • Rouet P, Dansette P, Frayssinet C. (1984). Ontogeny of benzo(a)pyrene hydroxylase, epoxide hydrolase and glutathione-S transferase in the brain, lung and liver of C57Bl/6 mice. Dev Pharmacol Ther 7:245–258.
  • Rout UK, Holmes RS. (1988). Postnatal development of mouse aldehyde dehydrogenases. Agarose-isoelectric focusing analyses of the heart, lung, skin and ocular isozymes. In: Kuriyama K, Takada A, Fshii H, eds. Biomedical and social aspects of alcohol and alcoholism. Amsterdam: Elsevier Science Publishers, 139–143.
  • Rout UK, Holmes RS. (1991). Postnatal development of mouse alcohol dehydrogenases: agarose isoelectric focusing analyses of the liver, kidney, stomach and ocular isozymes. Biol Neonate 59:93–97.
  • Saghir SA, Marty MS, Clark AJ, Zablotny CL, Bus JS, Perala AW, Yano BL, Neal BH. (2009). A dietary dose range-finding and toxicokinetic (TK) study of 2,4-dichlorophenoxyacetic acid (2,4-D) in adult CRL:CD(SD) rats and their offspring: I. toxicokinetics. The Toxicologist 108:1161.
  • Salman ED, Kadlubar SA, Falany CN. (2009). Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab Dispos 37:706–709.
  • Sawamura A, Kusunose E, Satouchi K, Kusunose M. (1993). Catalytic properties of rabbit kidney fatty acid omega-hydroxylase cytochrome P-450ka2 (CYP4A7). Biochim Biophys Acta 1168:30–36.
  • Scarborough PE, Ma J, Qu W, Zeldin DC. (1999). P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 31:205–234.
  • Schenkman JB, Choudhary D, Jansson I, Sarfaraze M, Stoilov I. (2003). Involvement of cytochromes P450 in development. Proc Indian Natl Sci Acad B69:929–941.
  • Schuetz JD, Beach DL, Guzelian PS. (1994). Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11–20.
  • Scheuplein RJ. (2000). Pesticides and infant risk: is there a need for an additional safety margin? Regul Toxicol Pharmacol 31:267–279.
  • Shamir R, Hartman C, Karry R, Pavlotzky E, Eliakim R, Lachter J, Suissa A, Aviram M. (2005). Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free Radic Biol Med 39:336–344.
  • Shehin-Johnson SE, Williams DE, Larsen-Su S, Stresser DM, Hines RN. (1995). Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit. J Pharmacol Exp Ther 272:1293–1299.
  • Shepard EA, Dolphin CT, Fox MF, Povey S, Smith R, Phillips IR. (1993). Localization of genes encoding three distinct flavin-containing monooxygenases to human chromosome 1q. Genomics 16:85–89.
  • Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. (1996b). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979–2984.
  • Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423.
  • Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng YF, Guengerich FP, Inui Y. (1996a). Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 24:515–522.
  • Simpson AE, Brammar WJ, Pratten MK, Elcombe CR. (1995). Translactational induction of CYP4A expression in 10.5-day neonatal rats by the hypolipidemic drug clofibrate. Biochem Pharmacol 50:2021–2032.
  • Simpson AE. (1997). The cytochrome P450 4 (CYP4) family. Gen Pharmacol 28:351–359.
  • Singh SV, Dao DD, Partridge CA, Theodore C, Srivastava SK, Awasthi YC. (1985). Different forms of human liver glutathione S-transferases arise from dimeric combinations of at least four immunologically and functionally distinct subunits. Biochem J 232:781–790.
  • Singh SV, Leal T, Ansari GA, Awasthi YC. (1987). Purification and characterization of glutathione S-transferases of human kidney. Biochem J 246:179–186.
  • Sipes IG, Gandolfi AJ. (1986). Biotransformation of Toxicants. In: Klaassen CD, Amdur MO, Doull J, eds. Casarett & Doull’s toxicology: the basic science of poisons. New York: MacMillan Publishing Co, 64–98.
  • Sjöblom M, Pilström L, Mørland J. (1978). Activity of alcohol dehydrogenase and acetaldehyde dehydrogenases in the liver and placenta during the development of the rat. Enzyme 23:108–115.
  • Smelt VA, Upton A, Adjaye J, Payton MA, Boukouvala S, Johnson N, Mardon HJ, Sim E. (2000). Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet 9:1101–1107.
  • Smith JN, Timchalk C, Bartels MJ, Poet TS. (2011). In vitro age-dependent enzymatic metabolism of chlorpyrifos and chlorpyrifos-oxon in human hepatic microsomes and chlorpyrifos-oxon in plasma. Drug Metab Dispos 39:1353–1362.
  • Smith M, Hopkinson DA, Harris H. (1971). Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet 34:251–271.
  • Smolen TN, Smolen A, van de Kamp JL. (1990). Developmental profile of hepatic alcohol and aldehyde dehydrogenase activities in long-sleep and short-sleep mice. Alcohol 7:69–74.
  • Sonnier M, Cresteil T. (1998). Delayed ontogenesis of CYP1A2 in the human liver. Eur J Biochem 251:893–898.
  • Stanley EL, Hume R, Coughtrie MW. (2005). Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol 240:32–42.
  • Stanley LA, Copp AJ, Pope J, Rolls S, Smelt V, Perry VH, Sim E. (1998). Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology 58:174–182.
  • Stejskalova L, Vecerova L, Peréz LM, Vrzal R, Dvorak Z, Nachtigal P, Pavek P. (2011). Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures. Toxicol Sci 123:26–36.
  • Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ. (2003). Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573–582.
  • Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, Hines RN. (2008). Developmental changes in human liver CYP2D6 expression. Drug Metab Dispos 36:1587–1593.
  • Strange RC, Davis BA, Faulder CG, Cotton W, Bain AD, Hopkinson DA, Hume R. (1985). The human glutathione S-transferases: developmental aspects of the GST1, GST2, and GST3 loci. Biochem Genet 23:1011–1028.
  • Strange RC, Howie AF, Hume R, Matharoo B, Bell J, Hiley C, Jones P, Beckett GJ. (1989). The development expression of alpha-, mu- and pi-class glutathione S-transferases in human liver. Biochim Biophys Acta 993:186–190.
  • Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP. (2002). Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259–265.
  • Strolin Benedetti M, Baltes EL. (2003). Drug metabolism and disposition in children. Fund Clin Pharmacol 17: 281–299.
  • Strum JM, Ito T, Philpot RM, DeSanti AM, McDowell EM. (1990). The immunocytochemical detection of cytochrome P-450 monooxygenase in the lungs of fetal, neonatal, and adult hamsters. Am J Respir Cell Mol Biol 2:493–501.
  • Su T, Sheng JJ, Lipinskas TW, Ding X. (1996). Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab Dispos 24:884–890.
  • Tangalakis K, Coghlan JP, Connell J, Crawford R, Darling P, Hammond VE, Haralambidis J, Penschow J, Wintour EM. (1989). Tissue distribution and levels of gene expression of three steroid hydroxylases in ovine fetal adrenal glands. Acta Endocrinol 120:225–232.
  • Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M, Kumai T, Takashima S, Imaoka S, Funae Y, Yabusaki Y, Kamataki T, Kobayashi S. (1997). A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci 61:2567–2574.
  • Tayama Y, Miyake K, Sugihara K, Kitamura S, Kobayashi M, Morita S, Ohta S, Kihira K. (2007). Developmental changes of aldehyde oxidase activity in young Japanese children. Clin Pharmacol Ther 81:567–572.
  • Tee LB, Gilmore KS, Meyer DJ, Ketterer B, Vandenberghe Y, Yeoh GC. (1992). Expression of glutathione S-transferase during rat liver development. Biochem J 282 (Pt 1):209–218.
  • Thompson CM, Sonawane B, Grafström RC. (2009). The ontogeny, distribution, and regulation of alcohol dehydrogenase 3: implications for pulmonary physiology. Drug Metab Dispos 37:1565–1571.
  • Timms GP, Holmes RS. (1981). Genetics and ontogeny of aldehyde dehydrogenase isozymes in th mouse: evidence for a locus controlling the inducibility of the liver microsomal isozyme. Biochem Genet 19:1223–1236.
  • Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T. (1997). Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 7:441–452.
  • Treluyer JM, Jacqz-Aigrain E, Alvarez F, Cresteil T. (1991). Expression of CYP2D6 in developing human liver. Eur J Biochem 202:583–588.
  • Tuteja N, Gonzalez FJ, Nebert DW. (1985). Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes. Dev Biol 112:177–184.
  • Upton A, Johnson N, Sandy J, Sim E. (2001). Arylamine N-acetyltransferases - of mice, men and microorganisms. Trends Pharmacol Sci 22:140–146.
  • van den Berg H, van den Anker JN, Beijnen JH. (2012). Cytostatic drugs in infants: a review on pharmacokinetic data in infants. Cancer Treat Rev 38:3–26.
  • van Lieshout EM, Knapen MF, Lange WP, Steegers EA, Peters WH. (1998). Localization of glutathione S-transferases alpha and pi in human embryonic tissues at 8 weeks gestational age. Hum Reprod 13:1380–1386.
  • Vida C, Corpas I, De la Fuente M, González EM. (2011). Age-related changes in xanthine oxidase activity and lipid peroxidation, as well as in the correlation between both parameters, in plasma and several organs from female mice. J Physiol Biochem 67:551–558.
  • Vieira I, Sonnier M, Cresteil T. (1996). Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem 238:476–483.
  • Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460–3468.
  • Wyde ME, Kirwan SE, Zhang F, Laughter A, Hoffman HB, Bartolucci-Page E, Gaido KW, Yan B, You L. (2005). Di-n-butyl phthalate activates constitutive androstane receptor and pregnane X receptor and enhances the expression of steroid-metabolizing enzymes in the liver of rat fetuses. Toxicol Sci 86:281–290.
  • Xie HG, Wood AJ, Kim RB, Stein CM, Wilkinson GR. (2004). Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics 5:243–272.
  • Xu Y, Agrawal S, Cook TJ, Knipp GT. (2008). Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Placenta 29:962–969.
  • Yamamoto S, Kusunose E, Matsubara S, Ichihara K, Kusunose M. (1986). Occurrence of cytochrome P-450 with prostaglandin omega-hydroxylase activity in rabbit placental microsomes. J Biochem 100:175–181.
  • Yang D, Pearce RE, Wang X, Gaedigk R, Wan YJ, Yan B. (2009). Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Biochem Pharmacol 77:238–247.
  • Yang HY, Lee QP, Rettie AE, Juchau MR. (1994). Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis. Mol Pharmacol 46:922–928.
  • Yang HY, Namkung MJ, Juchau MR. (1995). Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis. Biochem Pharmacol 49:717–726.
  • Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, Gaedigk A, Suver C, Zhong H, Leeder JS, Guengerich FP, Strom SC, Schuetz E, Rushmore TH, Ulrich RG, Slatter JG, Schadt EE, Kasarskis A, Lum PY. (2010). Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res 20:1020–1036.
  • Yanni SB, Annaert PP, Augustijns P, Ibrahim JG, Benjamin DK Jr, Thakker DR. (2010). In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3. Drug Metab Dispos 38:25–31.
  • Yeung CK, Lang DH, Thummel KE, Rettie AE. (2000). Immunoquantitation of FMO1 in human liver, kidney, and intestine. Drug Metab Dispos 28:1107–1111.
  • Yokotani N, Bernhardt R, Sogawa K, Kusunose E, Gotoh O, Kusunose M, Fujii-Kuriyama Y. (1989). Two forms of omega-hydroxylase toward prostaglandin A and laurate. cDNA cloning and their expression. J Biol Chem 264:21665–21669.
  • Yokotani N, Kusunose E, Sogawa K, Kawashima H, Kinosaki M, Kusunose M, Fujii-Kuriyama Y. (1991). cDNA cloning and expression of the mRNA for cytochrome P-450kd which shows a fatty acid omega-hydroxylating activity. Eur J Biochem 196:531–536.
  • Yoshimura R, Kusunose E, Yokotani N, Yamamoto S, Kubota I, Kusunose M. (1990). Purification and characterization of two forms of fatty acid omega-hydroxylase cytochrome P-450 from rabbit kidney cortex microsomes. J Biochem 108:544–548.
  • You L, Chan SK, Bruce JM, Archibeque-Engle S, Casanova M, Corton JC, Heck H. (1999). Modulation of testosterone-metabolizing hepatic cytochrome P-450 enzymes in developing Sprague-Dawley rats following in utero exposure to p,p’-DDE. Toxicol Appl Pharmacol 158:197–205.
  • Yun KU, Oh SJ, Oh JM, Kang KW, Myung CS, Song GY, Kim BH, Kim SK. (2010). Age-related changes in hepatic expression and activity of cytochrome P450 in male rats. Arch Toxicol 84:939–946.
  • Zaya MJ, Hines RN, Stevens JC. (2006). Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab Dispos 34:2097–2101.
  • Zeilinska E, Niewiaroski W, Bodalski J, Stanczyk A, Bolanowski W, Rebowski G. (1997). Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin Pharmacol Ther 62:635–642.
  • Zhao LZ, Huang M, Chen J, Ee PL, Chan E, Duan W, Guan YY, Hong YH, Chen X, Zhou S. (2006). Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats. Curr Drug Metab 7:577–587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.